title: Amniotic membrane and amniotic cells: potential therapeutic tools to combat tissue inflammation and fibrosis?
abstract: In addition to the placenta, umbilical cord and amniotic fluid, the amniotic membrane is emerging as an immensely valuable and easily accessible source of stem and progenitor cells. This concise review will focus on the stem/progenitor cell properties of human amniotic epithelial and mesenchymal stromal cells and evaluate the effects exerted by these cells and the amniotic membrane on tissue inflammation and fibrosis.
authors.affiliation: Monash Institute of Medical Research, Monash University, Clayton, Victoria 3168, Australia. ursula.manuelpillai@monash.edu
authors.forename: U
authors.initials: U
authors.lastname: Manuelpillai
authors.forename: Y
authors.initials: Y
authors.lastname: Moodley
authors.forename: C V
authors.initials: CV
authors.lastname: Borlongan
authors.forename: O
authors.initials: O
authors.lastname: Parolini
mesh_terms: D000650:Amnion / Q000166:cytology*; D000818:Animals; D002454:Cell Differentiation / Q000502:physiology; D005260:Female; D005355:Fibrosis / Q000601:surgery; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000166:cytology*; D011247:Pregnancy; D033581:Stem Cell Transplantation / Q000379:methods*; D013234:Stem Cells / Q000166:cytology*